Evidence map›Paper›PMID 40961262›Full record

ArticleAmerican journal of respiratory and critical care medicine2025

Let-7f-5p Has Antifibrotic Properties and Is Reduced in Circulatory Small Extracellular Vesicles in Progressive Idiopathic Pulmonary Fibrosis.

Dino B A Tan, Maike Stentenbach, Erin Bolitho, Chantalia Tedja, Erick Aresgado, Ching-Hsien Chen, Angela Linderholm, Justin Oldham, Yuben Moodley, AIPFR

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dino B A TanCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.ORCID 0000-0001-9108-2360
Maike StentenbachCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
Erin BolithoRoyal Perth Hospital, Perth, Western Australia, Australia.
Chantalia TedjaInstitute for Respiratory Health, Inc., Nedlands, Western Australia, Australia.
Erick AresgadoInstitute for Respiratory Health, Inc., Nedlands, Western Australia, Australia.
Ching-Hsien ChenUniversity of California, Davis, Davis, California.ORCID 0000-0002-4211-9988
Angela LinderholmUniversity of California, Davis, Davis, California.
Justin OldhamUniversity of Michigan, Ann Arbor, Michigan; and.ORCID 0000-0003-4957-8869
Yuben MoodleyCentre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.ORCID 0000-0002-0777-1196
AIPFR

Funding

Boehringer IngelheimLung Foundation AustraliaNational Health and Medical Research Council APP1066128National Health and Medical Research Council APP114776National Health and Medical Research Council APP2022914National Health and Medical Research Council GNT1116371National Health and Medical Research Council GNT2015613Roche Products
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40961262
PMCPMC12700245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.